| 1 | | $765B | $804.62 | -2.02% | |
| 2 | | $387B | $160.64 | +0.79% | |
| 3 | | $327B | $185.16 | +1.64% | |
| 4 | | $317B | $125.26 | -0.47% | |
| 5 | | $183B | $105.24 | -5.62% | |
| 6 | | $180B | $334.85 | +0.21% | |
| 7 | | $174B | $30.77 | +1.66% | |
| 8 | | $157B | $441.30 | +1.04% | |
| 9 | | $128B | $495.26 | +0.56% | |
| 10 | | $126B | $331.67 | +1.29% | |
| 11 | Regeneron Pharmaceuticals | $119B | $1,078.63 | +1.36% | |
| 12 | | $110B | $74.92 | +0.89% | |
| 13 | | $102B | $50.45 | +10.87% | |
| 14 | | $101B | $78.70 | +0.05% | |
| 15 | | $95.9B | $77.01 | +0.64% | |
| 16 | | $92.9B | $354.78 | +0.56% | |
| 17 | | $82.1B | $179.84 | -0.51% | |
| 18 | | $77.8B | $600.16 | +0.74% | |
| 19 | | $70.4B | $127.16 | +23.74% | |
| 20 | | $68.6B | $237.30 | +1.94% | |
| 21 | | $46.8B | $122.11 | +0.58% | |
| 22 | | $44.8B | $227.62 | +0.22% | |
| 23 | | $38.8B | $469.71 | -0.21% | |
| 24 | | $37.6B | $62.37 | +4.17% | |
| 25 | | $36.7B | $80.50 | +1.98% | |
